Ronovo Surgical successfully closed a $67 million Series D financing round led by Johnson & Johnson, enabling the company to enhance its innovative surgical robotics and expand its market presence in China and beyond.
Information on the Target
Ronovo Surgical, a company in the INCE Capital portfolio, is at the forefront of innovation in the surgical robotics industry. Specializing in next-generation surgical technologies, Ronovo Surgical has made notable advancements with its flagship product, Carina™, which is designed to provide flexible and affordable solutions for minimally invasive surgeries.
Recently, Ronovo Surgical successfully closed its Series D financing round on September 5, 2025, raising a total of USD $67 million. This funding round was led by Johnson & Johnson's corporate venture capital arm, JJDC, along with participation from Lilly Asia Ventures, INCE Capital, and Granite Asia. With over USD 100 million raised in 2025 alone, Ronovo is gaining strong support as it aims to revolutionize surgical practices worldwide.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in China
The surgical robotics market in China is rapidly evolving, driven by advancements in technology and a growing demand for minimally invasive surgical procedures. The introduct
Similar Deals
Adicon Holdings Limited → Crown Bioscience Inc.
2026
Johnson & Johnson
invested in
Ronovo Surgical
in 2025
in a Other deal
Disclosed details
Transaction Size: $67M